However, this seems to not always be the case, since very young AD transgenic mice, expressing a mutant version of tau and already accumulating hyperphosphorylated Tau protein, do not produce seizure-like activity in the presence of the potassium channel blocker 4-aminopyridine [4]. Here, MAPT is linked to Alzheimer disease.